Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 449
of 23Next
1:

Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour.

Demicheli R, Bonadonna G, Hrushesky WJ, Retsky MW, Valagussa P.

Breast Cancer Res. 2004;6(6):R689-96. Epub 2004 Oct 11.

PMID: 15535851 [PubMed - indexed for MEDLINE]

2:

Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy.

Demicheli R, Abbattista A, Miceli R, Valagussa P, Bonadonna G.

Breast Cancer Res Treat. 1996;41(2):177-85.

PMID: 8944336 [PubMed - indexed for MEDLINE]

3:

Double-peaked time distribution of mortality for breast cancer patients undergoing mastectomy.

Demicheli R, Valagussa P, Bonadonna G.

Breast Cancer Res Treat. 2002 Sep;75(2):127-34.

PMID: 12243505 [PubMed - indexed for MEDLINE]

4:

Clinical outcomes of post-operative locoregional radiotherapy in pre-menopausal and post-menopausal Chinese women with breast cancer.

Mok TS, Kwan WH, Yeo WM, Chan AT, Chan EC, Chak K, Chow DL, Lo C, Leung TW, Teo PM.

Radiother Oncol. 2000 Mar;54(3):201-8.

PMID: 10738077 [PubMed - indexed for MEDLINE]

5:

[Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results]

Fodor J, Mózsa E, Zaka Z, Polgár C, Major T.

Magy Onkol. 2005;49(3):203, 205-8. Epub 2005 Oct 25. Hungarian.

PMID: 16249814 [PubMed - indexed for MEDLINE]

6:

Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?

Rack B, Janni W, Gerber B, Strobl B, Schindlbeck C, Klanner E, Rammel G, Sommer H, Dimpfl T, Friese K.

Breast Cancer Res Treat. 2003 Nov;82(2):83-92.

PMID: 14692652 [PubMed - indexed for MEDLINE]

7:

Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer.

Voogd AC, de Boer R, van der Sangen MJ, Roumen RM, Rutten HJ, Coebergh JW.

Eur J Surg Oncol. 2001 Apr;27(3):250-5.

PMID: 11373100 [PubMed - indexed for MEDLINE]

8:

Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process.

Demicheli R, Miceli R, Moliterni A, Zambetti M, Hrushesky WJ, Retsky MW, Valagussa P, Bonadonna G.

Ann Oncol. 2005 Sep;16(9):1449-57. Epub 2005 Jun 14.

PMID: 15956037 [PubMed - indexed for MEDLINE]

9:

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID: 17993229 [PubMed - indexed for MEDLINE]

10:

The correlation between the spread of metastases by level in the axillary nodes and disease-free survival in breast cancer. A multifactorial analysis.

Gaglia P, Bussone R, Caldarola B, Lai M, Jayme A, Caldarola L.

Eur J Cancer Clin Oncol. 1987 Jun;23(6):849-54.

PMID: 3653201 [PubMed - indexed for MEDLINE]

11:

Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.

Truong PT, Olivotto IA, Kader HA, Panades M, Speers CH, Berthelet E.

Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1337-47.

PMID: 15817335 [PubMed - indexed for MEDLINE]

12:

Outpatient follow-up after treatment for early breast cancer: updated results after 5 years.

Churn M, Kelly V.

Clin Oncol (R Coll Radiol). 2001;13(3):187-94.

PMID: 11527293 [PubMed - indexed for MEDLINE]

13:

TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer.

Overgaard J, Yilmaz M, Guldberg P, Hansen LL, Alsner J.

Acta Oncol. 2000;39(3):327-33.

PMID: 10987229 [PubMed - indexed for MEDLINE]

14:

Ten year results of a randomised trial comparing two conservative treatment strategies for small size breast cancer.

Mariani L, Salvadori B, Marubini E, Conti AR, Rovini D, Cusumano F, Rosolin T, Andreola S, Zucali R, Rilke F, Veronesi U.

Eur J Cancer. 1998 Jul;34(8):1156-62.

PMID: 9849473 [PubMed - indexed for MEDLINE]

15:

Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.

Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH, Lee JH, Kang SS, Lee JE, Kang MK, Park YJ, Nam HR.

Jpn J Clin Oncol. 2005 Mar;35(3):126-33.

PMID: 15741302 [PubMed - indexed for MEDLINE]

16:

Significance of axillary lymph node metastasis in primary breast cancer.

Jatoi I, Hilsenbeck SG, Clark GM, Osborne CK.

J Clin Oncol. 1999 Aug;17(8):2334-40. Erratum in: J Clin Oncol 1999 Oct;17(10):3365.

PMID: 10561295 [PubMed - indexed for MEDLINE]

17:

The analysis of prognostic factors in stage III-B non-inflammatory breast cancer.

Yildirim E, Semerci E, Berberoğlu U.

Eur J Surg Oncol. 2000 Feb;26(1):34-8.

PMID: 10718177 [PubMed - indexed for MEDLINE]

18:

Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with node-negative breast cancer: a prospective cohort study.

Nottage MK, Kopciuk KA, Tzontcheva A, Andrulis IL, Bull SB, Blackstein ME.

Breast Cancer Res. 2006;8(4):R44.

PMID: 16859523 [PubMed - indexed for MEDLINE]

19:

Urinary testosterone as a marker of risk of recurrence in operable breast cancer.

Ballerini P, Oriana S, Duca P, Martinetti A, Venturelli E, Ferrari L, Dolci S, Secreto G.

Breast Cancer Res Treat. 1993;26(1):1-6.

PMID: 8400317 [PubMed - indexed for MEDLINE]

20:

Long-term review of a breast conservation series and patterns of care over 18 years.

Pendlebury SC, Ivanov O, Renwick S, Stevens GN.

ANZ J Surg. 2003 Aug;73(8):577-83.

PMID: 12887521 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 449
of 23Next